To further evaluate the role of DOT1L as well as to explore the consequences of blocking DOT1L binding to MLL-AF9 and its recruitment to MLL target genes, we established several MLL-AF9-transformed leukemia cell lines. The gene discussed is KMT2A; the disease is leukemia.